Long non‑coding RNA XIST promotes the proliferation of cardiac fibroblasts and the accumulation of extracellular matrix by sponging microRNA‑155‑5p
- Hongbin Zhang
- Jianfei Ma
- Fei Liu
- Jun Zhang
Affiliations: Department of Cardiology, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China
- Published online on: March 12, 2021 https://doi.org/10.3892/etm.2021.9908
Copyright: © Zhang
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Acute myocardial infarction (AMI) is characterized by cardiomyocyte death followed by myocardial fibrosis, eventually leading to heart failure. Long non‑coding (lnc)RNA X‑inactive specific transcript (XIST) serves a vital role in the regulation of fibrosis. The aim of the present study was to determine whether myocardial fibrosis may be regulated by XIST and to elucidate the underlying mechanism. The relative mRNA expression levels of the target genes were evaluated using reverse transcription‑quantitative polymerase chain reaction. Cell viability and apoptosis were determined using a Cell Counting Kit‑8 assay and flow cytometry, respectively. The apoptosis and fibrosis‑related protein expression levels were detected using western blot analysis. Finally, the interaction between XIST and microRNA (miR)‑155‑5p was analyzed using a luciferase reporter assay. XIST‑overexpression increased proliferation and the expression level of the fibrosis‑related proteins in the human cardiac fibroblast cells (HCFs). XIST directly targeted miR‑155‑5p and downregulated its expression, while miR‑155‑5p downregulation abolished the effect of XIST‑silencing on cell viability and the expression level of the fibrosis‑related proteins in the HCFs. XIST promoted cell proliferation and the expression level of fibrosis‑related proteins by sponging miR‑155‑5p. Therefore, XIST may represent a novel effective target for AMI treatment.